ARCHIVES

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

This article is from The Cancer Letter archive.

Vol. 35 No. 15 | April 17, 2009

Download PDF Visit The Full Archive

Related Articles

Univ. Of Pittsburg Vows To Make Changes To Keep NSABP

April 8, 1994

In Brief: Gift to Jefferson Funds Capizzi Professorship; Abrams Named Special Assistant to DDES

January 9, 1998

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

Older Women More Likely To Receive Lower Chemotherapy Doses, Study Finds

August 28, 2009

Guidelines Proposed For Control Grants

January 25, 1980

Preserve NCI’s Role In Applied Research And Its Unique Environment, Chabner Says

May 12, 1995